Riskpilot← Back to searchSign inGet full accessKirurgi Heden AB
ABActiveOrg 5590328315Engelbrektsgatan 59Medical specialists activities · NACE 8622Est. 20150 employees
Revenue 2025
SEK 5,9M
+6% vs 2024
EBITDA margin
19.8%
-5% vs 2024
Equity ratio
21.4%
Financial strength
Net profit 2025
SEK 141K
-4% vs 2024
| Revenue | SEK 5,9M | +6% |
| EBITDA | SEK 1,2M | -5% |
| Net profit | SEK 141K | -4% |
| Total assets | SEK 7,9M | -17% |
| Equity | SEK 1,7M | +9% |
| Employees | 0 | — |
Legal name
Kirurgi Heden AB
Org number
5590328315
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
2 november 2015
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att bedriva specialistläkarmottagning, utföra operationer, tillhandahålla föreläsningar och utbildning för olika personalkategorier inom vården, import och export av tillåtna medicinska varor och mediciner samt därmed förenlig verksamhet.
Address
Engelbrektsgatan 59
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 422 | 4 778 | 4 583 | 5 592 | 5 914 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 968 | 1 277 | 1 366 | 1 236 | 1 172 |
| Depreciation & amort. | −311 | −0 | −0 | −0 | −0 |
| EBIT | 1 657 | 1 277 | 1 366 | 1 236 | 1 172 |
| Net financials | — | −4 | 3 | 5 | 4 |
| Profit before tax | 1 256 | 1 272 | 374 | 211 | 185 |
| Tax | −270 | −264 | −84 | −64 | −44 |
| Net profit | 986 | 1 008 | 290 | 147 | 141 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 11 389 | 13 994 | 10 294 | 9 591 | 7 934 |
| Equity | 3 210 | 3 618 | 1 408 | 1 555 | 1 695 |
| Long-term debt | 0 | 5 887 | 7 605 | 6 347 | 4 760 |
| Short-term debt | 6 831 | 3 140 | 48 | 625 | 623 |
| Total debt | 6 831 | 9 027 | 7 653 | 6 972 | 5 383 |
EBITDA margin
19.8%
This company
15.8%
Market median
+25% vs market
20212025
Equity ratio
21.4%
This company
38.2%
Market median
-44% vs market
20212025
Return on equity
8.3%
This company
18.4%
Market median
-55% vs market
20212025
Net profit margin
2.4%
This company
8.1%
Market median
-70% vs market
20212025
Asset turnover
0.75×
This company
1.12×
Market median
-33% vs market
20212025
Debt / equity
3.68×
This company
0.62×
Market median
-494% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LM Audit | Audit | 2022 |
MM Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Akutläkarna Holding AB
Kirurgi Heden AB Board members of Kirurgi Heden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Magnus Frisk | Audit | 0 companies |
| Mehran Monemi | Chief Executive Officer | 0 companies |
| Shoaleh Mohtadi-Tabrizi | Deputy Board Member | 0 companies |